FindTrial
Sign In

Evaluation of Articaine used as Nerve Block with Buccal Injection and Intraligamentary injection with Buccal and Lingual Injection in mandibular molars with Symptoms of Irreversible Pulpitis- A Prospective, Randomized Controlled Trial

Comparative evaluation of 4% Articaine used as Inferior Alveolar Nerve Block with Buccal Infiltration and Intraligamentary injection with Buccal and Lingual Infiltration in mandibular molars with Symptomatic Irreversible Pulpitis- A Prospective, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023231
Enrollment
140
Registered
2020-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Dr Aditi Goel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with irreversible pulpitis in mandibular first or/and second molars on both right and left sides, Those aged 25-45 yrs, Those in good health, with no previous history of allergy to any kind of local anesthesia, sulphites or other drugs that would alter pain perception, Prolonged response to cold testing with Endo-frost (RoekoLangenace, Germany), A vital coronal pulp on access opening, No history of trauma to the involved tooth

Exclusion criteria

Exclusion criteria: Patients with periapical pathology or any periapical radiolucency on rediograph Retreatment cases Cases with Non vital pulp Pregnancy or lactating patients Patients unable to give informed consent Those with allergies to local anesthetic agent or sulphites or sulphur drugs Those taking CNS depressants or any analgesic medication within 12 hrs

Design outcomes

Primary

MeasureTime frame
The purpose of the study is Comparative evaluation of 4% Articaine used as Inferior Alveolar Nerve Block with Buccal Infiltration and Intraligamentary injection with Buccal and Lingual Infiltration in mandibular molars with Symptomatic Irreversible Pulpitis.Timepoint: after 15 mins of LA administration—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Aditi Goel

SGT Dental College, Gurugram

drmandeepsgrewal@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026